195 related articles for article (PubMed ID: 21080854)
1. Sertindole for the treatment of schizophrenia.
Azorin JM; Kaladjian A; Fakra E; Adida M
Expert Opin Pharmacother; 2010 Dec; 11(18):3053-64. PubMed ID: 21080854
[TBL] [Abstract][Full Text] [Related]
2. Drug safety and efficacy evaluation of sertindole for schizophrenia.
Karamatskos E; Lambert M; Mulert C; Naber D
Expert Opin Drug Saf; 2012 Nov; 11(6):1047-62. PubMed ID: 22992213
[TBL] [Abstract][Full Text] [Related]
3. Emerging treatments in the management of schizophrenia - focus on sertindole.
Muscatello MR; Bruno A; Pandolfo G; Micò U; Settineri S; Zoccali R
Drug Des Devel Ther; 2010 Sep; 4():187-201. PubMed ID: 20856845
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sertindole in schizophrenia: a clinical review.
Zoccali RA; Bruno A; Muscatello MR
J Clin Psychopharmacol; 2015 Jun; 35(3):286-95. PubMed ID: 25830594
[TBL] [Abstract][Full Text] [Related]
5. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
[TBL] [Abstract][Full Text] [Related]
6. Sertindole: a review of clinical efficacy.
Kane JM
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S59-63; discussion S63-4. PubMed ID: 9690972
[TBL] [Abstract][Full Text] [Related]
7. A review of the efficacy, tolerability and safety of sertindole in clinical trials.
Perquin L; Steinert T
CNS Drugs; 2004; 18 Suppl 2():19-30; discussion 41-3. PubMed ID: 15461313
[TBL] [Abstract][Full Text] [Related]
8. Do we need another atypical antipsychotic?
Kasper S
Eur Neuropsychopharmacol; 2008 Aug; 18 Suppl 3():S146-52. PubMed ID: 18511242
[TBL] [Abstract][Full Text] [Related]
9. The Sertindole Cohort Prospective (SCoP) study: rationale, design and methodology.
Peuskens J; Tanghøj P; Mittoux A;
Pharmacoepidemiol Drug Saf; 2008 May; 17(5):425-33. PubMed ID: 18384186
[TBL] [Abstract][Full Text] [Related]
10. Sertindole in schizophrenia: efficacy and safety issues.
Muscatello MR; Bruno A; Micali Bellinghieri P; Pandolfo G; Zoccali RA
Expert Opin Pharmacother; 2014 Sep; 15(13):1943-53. PubMed ID: 25084209
[TBL] [Abstract][Full Text] [Related]
11. The European Post-marketing Observational Serdolect (EPOS) Project: increasing our understanding of schizophrenia therapy.
Wehnert A
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S27-30. PubMed ID: 9690967
[TBL] [Abstract][Full Text] [Related]
12. Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.
Brown LA; Levin GM
Pharmacotherapy; 1998; 18(1):69-83. PubMed ID: 9469684
[TBL] [Abstract][Full Text] [Related]
13. The atypical antipsychotic sertindole: a case series.
Lee AM; Knoll JL; Suppes T
J Clin Psychiatry; 1997 Sep; 58(9):410-6; quiz 417-8. PubMed ID: 9378698
[TBL] [Abstract][Full Text] [Related]
14. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
[TBL] [Abstract][Full Text] [Related]
15. Ejaculatory dysfunction in patient with schizophrenia on sertindole.
Jukić MK; Drmić S; Mimica N
Psychiatr Danub; 2010 Mar; 22(1):128-31. PubMed ID: 20305609
[TBL] [Abstract][Full Text] [Related]
16. Marked elevation of creatine kinase with sertindole: a case report.
Oulis P; Koulouris GC; Konstantakopoulos G; Masdrakis VG
Pharmacopsychiatry; 2007 Nov; 40(6):295-6. PubMed ID: 18030658
[No Abstract] [Full Text] [Related]
17. Sertindole versus haloperidol for schizophrenia.
Mattes JA
Am J Psychiatry; 1998 Sep; 155(9):1303; author reply 1303-4. PubMed ID: 9734567
[No Abstract] [Full Text] [Related]
18. Sertindole in the long-term treatment of schizophrenia.
Hale AS; Azorin JM; Lemming OM; Mæhlum E
Int Clin Psychopharmacol; 2012 Jul; 27(4):231-7. PubMed ID: 22609816
[TBL] [Abstract][Full Text] [Related]
19. Sertindole : a review of its use in schizophrenia.
Murdoch D; Keating GM
CNS Drugs; 2006; 20(3):233-55. PubMed ID: 16529528
[TBL] [Abstract][Full Text] [Related]
20. Dose-response relationship of sertindole and haloperidol using the pharmacopsychometric triangle.
Bech P; Tanghøj P; Andreasson K; Overø KF
Acta Psychiatr Scand; 2011 Feb; 123(2):154-61. PubMed ID: 20560900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]